Covered recipient · General Payments record
LOVA L SUN
Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology
General Payments · PY2021–2025
$26,038.63
- Reported across 28 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $7,360.00 | 2 |
| Travel and Lodging | $807.19 | 4 |
| Food and Beverage | $230.47 | 3 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| GlaxoSmithKline, LLC. | $5,783.74 | 7 |
| AstraZeneca UK Limited | $2,460.00 | 1 |
| Merck Sharp & Dohme Corporation | $153.92 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AstraZeneca UK Limited | $2,460.00 | 01/10/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1202979248 | CMS |
| GlaxoSmithKline, LLC. | $508.20 | 04/30/2025 | Travel and Lodging | Undisputed | 06/30/2026 | 1190760082 | CMS |
| GlaxoSmithKline, LLC. | $31.41 | 04/30/2025 | Travel and Lodging | Undisputed | 06/30/2026 | 1191644383 | CMS |
| GlaxoSmithKline, LLC. | $190.63 | 05/15/2025 | Travel and Lodging | Undisputed | 06/30/2026 | 1191782071 | CMS |
| GlaxoSmithKline, LLC. | $52.41 | 05/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1190346150 | CMS |
| GlaxoSmithKline, LLC. | $76.95 | 07/07/2025 | Travel and Lodging | Undisputed | 06/30/2026 | 1190677989 | CMS |
| GlaxoSmithKline, LLC. | $24.14 | 07/07/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1191028373 | CMS |
| GlaxoSmithKline, LLC. | $4,900.00 | 07/11/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1191047039 | CMS |
| Merck Sharp & Dohme LLC | $153.92 | 11/13/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1238104649 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2021, 2022, 2023, 2024, 2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.